Enzon Pharmaceuticals, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €22.40K +∞% €670.29K +693.9% 2,992.3% +30 pp €966.66K -14.0% 4,315.4% +43 pp
    €0.00 -100.0% €84.43K -152.7% N/A €1.12M -298.0% N/A
    €22.40K -96.3% -€160.25K -60.3% -715.4% -6.5 pp -€567.76K +31.5% -2,534.6% -25 pp
    €603.95K +1,248.1% -€404.07K -64.2% -66.9% +25 pp -€431.64K +31.8% -71.5% +6.6 pp
    €44.80K -74.9% -€1.13M +33.9% -2,521.2% -20 pp -€327.39K -105.5% -730.8% -41 pp
    €178.34K -97.0% -€843.46K -116.7% -472.9% -5.6 pp €5.95M -806.0% 3,335.7% +33 pp
    €5.96M -17.4% €5.04M +7.4% 84.5% +0.20 pp -€842.59K -115.1% -14.1% -0.91 pp
    €7.22M +0.0% €4.69M -583.6% 65.0% +0.78 pp €5.58M +149.0% 77.2% +0.46 pp
    €7.22M -52.0% -€970.10K -105.2% -13.4% -1.4 pp €2.24M -82.3% 31.0% -0.53 pp
    €15.04M -44.0% €18.64M -24.9% 124.0% +0.32 pp €12.65M -54.6% 84.1% -0.20 pp
    €26.86M -9.6% €24.81M +58.7% 92.4% +0.40 pp €27.86M +130.5% 103.7% +0.63 pp
    €29.72M -19.0% €15.64M -752.2% 52.6% +0.59 pp €12.09M +65.5% 40.7% +0.21 pp
    €36.70M -11.4% -€2.40M -86.6% -6.5% +0.37 pp €7.30M -170.1% 19.9% +0.45 pp
    €41.42M -50.9% -€17.89M -111.7% -43.2% -2.2 pp -€10.42M -149.2% -25.2% -0.50 pp
    €84.32M -47.0% €152.70M +25,850.7% 181.1% +1.8 pp €21.18M +10.7% 25.1% +0.13 pp
    €159.06M -6.3% €588.44K -125.2% 0.4% +0.017 pp €19.13M -42.2% 12.0% -0.075 pp
    €169.67M +6.1% -€2.34M -103.3% -1.4% -0.46 pp €33.08M -71.7% 19.5% -0.54 pp
    €159.90M -0.0% €71.55M +289.8% 44.7% +0.33 pp €116.73M +54.0% 73.0% +0.26 pp
    €159.95M +11.7% €18.36M -123.8% 11.5% +0.65 pp €75.82M +246.9% 47.4% +0.32 pp
    €143.23M -2.0% -€77.20M -2,229.4% -53.9% -0.56 pp €21.85M -64.6% 15.3% -0.27 pp
    €146.09M +123.7% €3.63M -90.8% 2.5% -0.58 pp €61.81M +34.7% 42.3% -0.28 pp
    €65.31M +140.0% €39.46M +0.0% 60.4% -0.85 pp €45.88M +597.3% 70.2% +0.46 pp
    €27.21M +85.6% €39.46M +297.4% 145.0% +0.77 pp €6.58M -224.2% 24.2% +0.60 pp
    €14.66M +28.9% €9.93M -282.8% 67.7% +1.2 pp -€5.30M +80.8% -36.1% -0.10 pp
    €11.37M +0.0% -€5.43M +28.7% -47.8% -0.11 pp -€2.93M +6.3% -25.8% -0.015 pp
    €11.37M +3.9% -€4.22M +36.1% -37.1% -0.088 pp -€2.76M -3.0% -24.2% +0.017 pp
    €10.94M +0.0% -€3.10M -21.7% -28.3% +0.079 pp -€2.84M -29.8% -26.0% +0.11 pp
    €10.94M +0.0% -€3.96M -11.5% -36.2% +0.047 pp -€4.05M +176.5% -37.0% -0.24 pp
    €10.94M -19.6% -€4.48M -17.5% -40.9% -0.011 pp -€1.46M -85.6% -13.4% +0.61 pp
    €13.61M +6.8% -€5.43M -61.8% -39.9% +0.72 pp -€10.17M -33.3% -74.7% +0.45 pp
    €12.75M +76.2% -€14.22M -32.9% -111.5% +1.8 pp -€15.25M +27.3% -119.6% +0.46 pp
    €7.24M +47.4% -€21.19M -12.8% -292.9% +2.0 pp -€11.98M +107.5% -165.5% -0.48 pp
    €4.91M +128.0% -€24.30M +135.0% -494.7% -0.15 pp -€5.77M +24.1% -117.5% +0.98 pp
    €2.15M +0.0% -€10.34M +50.0% -480.0% -1.6 pp -€4.65M +2,600.0% -216.0% -2.1 pp
    €2.15M -7.4% -€6.89M +60.0% -320.0% -1.3 pp -€172.31K -90.9% -8.0% +0.73 pp
    €2.33M +2,600.0% -€4.31M +13.6% -185.2% +42 pp -€1.90M +0.0% -81.5% +21 pp
    €86.15K +0.0% -€3.79M +91.3% -4,400.0% -21 pp -€1.90M +46.7% -2,200.0% -7.0 pp
    €86.15K +0.0% -€1.98M +35.3% -2,300.0% -6.0 pp -€1.29M +87.5% -1,500.0% -7.0 pp
    €86.15K +∞% -€1.46M +183.3% -1,700.0% -17 pp -€689.24K +700.0% -800.0% -8.0 pp
    €0.00 -€516.93K N/A -€86.15K N/A

    Notifications